247
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients

, , , ORCID Icon, , ORCID Icon, , , , ORCID Icon & show all
Pages 1077-1090 | Received 20 Aug 2022, Accepted 28 Apr 2023, Published online: 07 Jun 2023

References

  • May SM, Li JTC. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015;36(1):4–10. doi:10.2500/aap.2015.36.3812
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5). doi:10.1183/13993003.00164-2019
  • Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
  • Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440. doi:10.1378/chest.121.5.1434
  • Haruna A, Muro S, Nakano Y, et al. CT scan findings of emphysema predict mortality in COPD. Chest. 2010;138(3):635–640. doi:10.1378/chest.09-2836
  • Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
  • Taylan M, Demir M, Kaya H, et al. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Clin Respir J. 2017;11(3):311–317. doi:10.1111/crj.12336
  • Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–1060. doi:10.1016/j.rmed.2013.03.007
  • Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr. 2008;27(1):5–15. doi:10.1016/j.clnu.2007.10.007
  • Muramatsu N, Akiyama H. Japan: super-aging society preparing for the future. Gerontologist. 2011;51(4):425–432. doi:10.1093/geront/gnr067
  • Kaur D, Rasane P, Singh J, et al. Nutritional interventions for elderly and considerations for the development of geriatric foods. Curr Aging Sci. 2019;12(1):15–27. doi:10.2174/1874609812666190521110548
  • Cheng YL, Sung SH, Cheng HM, et al. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. J Am Heart Assoc. 2017;6(6). doi:10.1161/JAHA.116.004876
  • Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139(1):160–167. doi:10.1016/0002-9610(80)90246-9
  • Onodera T, Goseki N, Kosaki G. ”StageIV・V (Vは大腸癌) 消化器癌の非治癒切除・姑息手術に対するTPNの適応と限界 [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–1005. Japanese.
  • Zhang Q, Bao J, Zhu ZY, Jin MX. Prognostic nutritional index as a prognostic factor in lung cancer patients receiving chemotherapy: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25(18):5636–5652. doi:10.26355/eurrev_202109_26783
  • Kim SI, Kim SJ, Kim SJ, Cho DS. Prognostic nutritional index and prognosis in renal cell carcinoma: a systematic review and meta-analysis. Urol Oncol. 2021;39(10):623–630. doi:10.1016/j.urolonc.2021.05.028
  • Demirelli B, Babacan NA, Ercelep O, et al. Modified Glasgow prognostic score, prognostic nutritional index and ECOG performance score predicts survival better than sarcopenia, cachexia and some inflammatory indices in metastatic gastric cancer. Nutr Cancer. 2021;73(2):230–238. doi:10.1080/01635581.2020.1749290
  • Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861. doi:10.1164/ajrccm.160.6.9902115
  • Raad S, Smith C, Allen K. Nutrition status and chronic obstructive pulmonary disease: can we move beyond the body mass index? Nutr Clin Pract. 2019;34(3):330–339. doi:10.1002/ncp.10306
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Nishimura M, Aizawa H, Kambe M, et al. 日本呼吸器学会呼吸機能検査ガイドライン ースパイロメトリー,フローボリューム曲線,肺拡散能カー [Guideline of respiratory function tests--spirometry, flow-volume curve, diffusion capacity of the lung]. Nihon Kokyuki Gakkai zasshi. 2004:1–56. Japanese. Japanese: https://europepmc.org/article/MED/15565748.
  • Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
  • Kwon N, Amin M, Hui DS, et al. Validity of the COPD assessment test translated into local languages for Asian patients. Chest. 2013;143(3):703–710. doi:10.1378/chest.12-0535
  • Shimada A, Kawata N, Sato H, et al. Dynamic quantitative magnetic resonance imaging assessment of areas of the lung during free-breathing of patients with chronic obstructive pulmonary disease. Acad Radiol. 2022;29(Suppl 2):S215–S225. doi:10.1016/j.acra.2021.03.034
  • Tanabe N, Muro S, Hirai T, et al. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(12):1653–1659. doi:10.1164/rccm.201009-1535OC
  • Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med. 2012;185(11):1218–1224. doi:10.1164/rccm.201110-1843OC
  • Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.847
  • Lim JU, Kim EK, Lim SY, et al. Mixed phenotype of emphysema and airway wall thickening is associated with frequent exacerbation in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2019;14:3035–3042. doi:10.2147/copd.S227377
  • Huang Y, Ding K, Dai Z, et al. The relationship of low-density-lipoprotein to lymphocyte ratio with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2022;17:2175–2185. doi:10.2147/copd.S369161
  • Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):8. doi:10.1109/TAC.1974.1100705
  • Mochizuki Y, Tanaka H, Matsumoto K, et al. Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus. Cardiovasc Diabetol. 2015;14:37. doi:10.1186/s12933-015-0201-8
  • Xu B, Kawata T, Daimon M, et al. Prognostic value of a simple echocardiographic parameter, the right ventricular systolic to diastolic duration ratio, in patients with advanced heart failure with non-ischemic dilated cardiomyopathy. Int Heart J. 2018;59(5):968–975. doi:10.1536/ihj.17-475
  • Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status?. JPEN J Parenter Enteral Nutr. 1987;11(1):8–13. doi:10.1177/014860718701100108
  • Hu Y, Yang H, Zhou Y, et al. Prediction of all-cause mortality with malnutrition assessed by nutritional screening and assessment tools in patients with heart failure: asystematic review. Nutr Metab Cardiovasc Dis. 2022;32(6):1361–1374. doi:10.1016/j.numecd.2022.03.009
  • Zhang Q, Qian L, Liu T, et al. Prevalence and prognostic value of malnutrition among elderly cancer patients using three scoring systems. Front Nutr. 2021;8:738550. doi:10.3389/fnut.2021.738550
  • Mirili C, Yılmaz A, Demirkan S, Bilici M, Basol Tekin S. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. Int J Clin Oncol. 2019;24(10):1301–1310. doi:10.1007/s10147-019-01461-7
  • Ge K, Fang C, Zhu D, et al. The prognostic value of the Prognostic Nutritional Index (PNI) in radically resected esophagogastric junction adenocarcinoma. Nutr Cancer. 2021;73(11–12):2589–2596. doi:10.1080/01635581.2020.1841252
  • Matsubara T, Takamori S, Haratake N, et al. The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab. J Thorac Dis. 2020;12(4):1520–1528. doi:10.21037/jtd.2020.02.27
  • Wei W, Wu X, Jin C, et al. Predictive significance of the Prognostic Nutritional Index (PNI) in patients with severe COVID-19. J Immunol Res. 2021;2021:9917302. doi:10.1155/2021/9917302
  • Liu G, Zhang S, Mao Z, Wang W, Hu H. Clinical significance of nutritional risk screening for older adult patients with COVID-19. Eur J Clin Nutr. 2020;74(6):876–883. doi:10.1038/s41430-020-0659-7
  • Yoshikawa M, Fujita Y, Yamamoto Y, et al. Mini Nutritional Assessment Short-Form predicts exacerbation frequency in patients with chronic obstructive pulmonary disease. Respirology. 2014;19(8):1198–1203. doi:10.1111/resp.12380
  • Shimizu K, Tanabe N, Tho NV, et al. Per cent low attenuation volume and fractal dimension of low attenuation clusters on CT predict different long-term outcomes in COPD. Thorax. 2020;75(2):116–122. doi:10.1136/thoraxjnl-2019-213525
  • Shoji F, Takeoka H, Kozuma Y, et al. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Lung Cancer. 2019;136:45–51. doi:10.1016/j.lungcan.2019.08.006
  • Beauchamp MK, Ellerton C, Kirkwood R, et al. Feasibility of a 6-month home-based fall prevention exercise program in older adults with COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:1569–1579. doi:10.2147/copd.S309537
  • Kawata T, Ikeda A, Masuda H, Komatsu S. Changes in prognostic nutritional index during hospitalization and outcomes in patients with acute heart failure. Heart Vessels. 2022;37(1):61–68. doi:10.1007/s00380-021-01888-x
  • Matsumura T, Mitani Y, Oki Y, et al. Comparison of Geriatric Nutritional Risk Index scores on physical performance among elderly patients with chronic obstructive pulmonary disease. Heart Lung. 2015;44(6):534–538. doi:10.1016/j.hrtlng.2015.08.004
  • Pascual-Gonzalez Y, Lopez-Sanchez M, Dorca J, Santos S. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2018;13:3651–3662. doi:10.2147/COPD.S178068
  • Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–e12. doi:10.1016/j.jinf.2020.04.002
  • Haram A, Boland MR, Kelly ME, Bolger JC, Waldron RM, Kerin MJ. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review. J Surg Oncol. 2017;115(4):470–479. doi:10.1002/jso.24523
  • Wang J, Liu Y, Mi X, Shao M, Liu L. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. Ann Palliat Med. 2020;9(3):967–978. doi:10.21037/apm.2020.04.31
  • Leung JM, Sin DD. Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ. 2017;358:j3772. doi:10.1136/bmj.j3772
  • Suzuki M, Makita H, Ito YM, Nagai K, Konno S, Nishimura M. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Multicenter study observational study research support, Non-U.S. Gov’t. Eur Respir J. 2014;43(5):1289–1297. doi:10.1183/09031936.00110213
  • Park SY, Kim S, Kim JH, et al. A randomized, noninferiority trial comparing ICS + LABA with ICS + LABA + LAMA in asthma-COPD overlap (ACO) treatment: the ACO Treatment with Optimal Medications (ATOMIC) study. J Allergy Clin Immunol Pract. 2021;9(3):1304–1311.e2. doi:10.1016/j.jaip.2020.09.066
  • Sugawara K, Takahashi H, Kasai C, et al. Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD. Respir Med. 2010;104(12):1883–1889. doi:10.1016/j.rmed.2010.05.008